Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effects of Lumbopelvic Manipulation on Hip and Knee Neuromuscular Activity

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2014 by Texas Woman's University
Sponsor:
Information provided by (Responsible Party):
Texas Woman's University
ClinicalTrials.gov Identifier:
NCT01637480
First received: June 25, 2012
Last updated: November 13, 2014
Last verified: November 2014
  Purpose

The purpose of this study is to determined if a lower back treatment would change the hip and knee muscle activities in people with and without anterior knee pain. The investigators hypothesized that the lower back treatment may change the hip and knee muscle activities in people with anterior knee pain but not in people without anterior knee pain.


Condition Intervention
Patellofemoral Pain Syndrome
Other: Lumbopelvic manipulation

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Effects of Lumbopelvic Manipulation on Hip and Knee Neuromuscular Activity in People With and Without Patellofemoral Pain Syndrome

Further study details as provided by Texas Woman's University:

Primary Outcome Measures:
  • Electromyography (EMG) [ Time Frame: The EMG data will be collected within 48 hours for all participants in both groups. On Day 1, data will be collected twice at baseline. On Day 2, data will be collected before and immediately after as well as 15, 30, and 45 min after the intervention. ] [ Designated as safety issue: No ]
    Electromyography (EMG) onset time of the gluteus maximus, gluteus medius, vastus medialis oblique, and vastus lateralis muscles.


Secondary Outcome Measures:
  • Pain Visual Analog Scale (VAS) [ Time Frame: The Pain Visual Analog Scale (VAS) will be assessed before and 45 min after the lower back treatment (lumbopelvic manipulation) for participants in the patellofemoral pain syndrome group on Day 2 only. ] [ Designated as safety issue: No ]
    Pain Visual Analog Scale (VAS) is a 100 mm continuous line between two end-points. The left end-point represents "no pain" and the right end-point represents the "worst pain imaginable".


Estimated Enrollment: 30
Study Start Date: July 2012
Estimated Study Completion Date: December 2015
Estimated Primary Completion Date: December 2015 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Patellofemoral Pain Syndrome
Participants with Patellofemoral Pain Syndrome
Other: Lumbopelvic manipulation
High-velocity-low-amplitude thrust manipulation of the lumbopelvic region
Active Comparator: Healthy control
Age- and gender-matched participants without Patellofemoral Pain Syndrome
Other: Lumbopelvic manipulation
High-velocity-low-amplitude thrust manipulation of the lumbopelvic region

  Eligibility

Ages Eligible for Study:   18 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria for participants in the patellofemoral pain syndrome group:

  1. insidious onset of symptoms of non-traumatic origin
  2. pain with patellar facet palpation or compression
  3. subjective knee pain rating of at least 3/10 on the pain visual analog scale during at least one of the following activities:

    • ascending stair
    • descending stair
    • kneeling
    • squatting
    • running
    • jumping
    • prolong sitting for more than 20 minutes

Exclusion criteria for all participants:

  1. history of spine, hip or knee surgery
  2. history of hip pathology or other knee condition
  3. current significant injury of any lower extremity joints
  4. pregnancy
  5. sign of nerve root compression
  6. osteoporosis or history of compression fracture

Age- and gender- matched control participants will be recruited if they have no signs or symptoms of patellofemoral pain syndrome and have none of the exclusion criteria

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01637480

Locations
United States, Texas
Texas Woman's University, School of Physical Therapy - Dallas Campus Recruiting
Dallas, Texas, United States, 75235
Contact: Ammar M Al Abbad, Master    214-689-6745 ext 2    aalabbad@twu.edu   
Sponsors and Collaborators
Texas Woman's University
Investigators
Principal Investigator: Ammar M Al Abbad, Master Texas Woman's University
  More Information

No publications provided

Responsible Party: Texas Woman's University
ClinicalTrials.gov Identifier: NCT01637480     History of Changes
Other Study ID Numbers: 16882
Study First Received: June 25, 2012
Last Updated: November 13, 2014
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Patellofemoral Pain Syndrome
Syndrome
Disease
Joint Diseases
Musculoskeletal Diseases
Pathologic Processes

ClinicalTrials.gov processed this record on November 27, 2014